4.7 Article

Evidence of Oral Translocation of Anionic G6.5 Dendrimers in Mice

Journal

MOLECULAR PHARMACEUTICS
Volume 10, Issue 3, Pages 988-998

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/mp300436c

Keywords

polymer therapeutics; oral translocation; bioavailability; PAMAM dendrimers; drug delivery

Funding

  1. National Institutes of Health [R01EB007470, R01DE019050]
  2. Utah Science Technology and Research (USTAR) initiative
  3. University of Utah

Ask authors/readers for more resources

Development of carrier systems to improve oral bioavailability and target drugs to specific sites continues to be an unmet need. The goal of this study was to evaluate the potential of anionic generation (G) 6.5 poly(amido amine) (PAMAM) dendrimers in oral drug delivery by assessing their in vivo oral translocation. G6.5-COOH dendrimers were characterized for their physiochemical characteristics and acute oral toxicity was assessed in CD-1 mice. The dendrimers were labeled with I-125 and their stability evaluated. Oral bioavailability was assessed in the same mouse model. Investigation of the radioactivity profile in plasma revealed presence of both large and small molecular weight compounds. Detailed area under the curve analysis suggests an effective 9.4% bioavailability of radiolabeled marker associated with G6.5-COOH. Results reported here suggest the potential of dendrimers in permeating gastrointestinal barriers in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available